Cleared Traditional

STRATUS DIGOXIN FLOUROMETRIC ENZYME IMMUNOASSAY

K934003 · Baxter Diagnostics, Inc. · Toxicology
Nov 1994
Decision
462d
Days
Class 2
Risk

About This 510(k) Submission

K934003 is an FDA 510(k) clearance for the STRATUS DIGOXIN FLOUROMETRIC ENZYME IMMUNOASSAY, a Antiserum, Digoxin (Class II — Special Controls, product code DKA), submitted by Baxter Diagnostics, Inc. (Mcgaw Park, US). The FDA issued a Cleared decision on November 22, 1994, 462 days after receiving the submission on August 17, 1993. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3320.

Submission Details

510(k) Number K934003 FDA.gov
FDA Decision Cleared SESE
Date Received August 17, 1993
Decision Date November 22, 1994
Days to Decision 462 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code DKA — Antiserum, Digoxin
Device Class Class II — Special Controls
CFR Regulation 21 CFR 862.3320